Partial Cystectomy Does Not Undermine Cancer Control in Appropriately Selected Patients With Urothelial Carcinoma of the Bladder: A Population-based Matched Analysist

Urology

Volumn 74, Issue 4, 2009, Pages 858-864

  Capitanio, Umberto ^a,b   Isbarn, Hendrik ^b,c   Shariat, Shahrokh F ^b   Jeldres, Claudio ^b,d   Zini, Laurent ^b,e   Saad, Fred ^d   Graefen, Markus ^c   Montorsi, Francesco ^a   Perrotte, Paul ^d   Karakiewicz, Pierre I ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CONTROL; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 70349437317     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.03.052     Document Type: Article

References (23)

1. Sweeney P., Kursh E.D., and Resnick M.I. Partial cystectomy. Urol Clin North Am 19 (1992) 701
2. Hollenbeck B.K., Taub D.A., Dunn R.L., et al. Quality of care: partial cystectomy for bladder cancer-a case of inappropriate use?. J Urol 174 (2005) 1050
3. Montie J.E., Abrahams N.A., Bahnson R.R., et al. Bladder cancer. Clinical guidelines in oncology. J Natl Compr Cancer Netw 4 (2006) 984
4. Smaldone M.C., Jacobs B.L., Smaldone A.M., et al. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma. Urology 72 (2008) 613
5. Kassouf W., Swanson D., Kamat A.M., et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M.D. Anderson Cancer Center experience. J Urol 175 (2006) 2058
6. Holzbeierlein J.M., Lopez-Corona E., Bochner B.H., et al. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol 172 (2004) 878
7. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004; National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2004/, based on November 2006 SEER data submission, posted to the SEER web site. Accessed January 2007.
8. Acher P.L., Morris S.L., Popert R.J., et al. Permanent prostate brachytherapy: a century of technical evolution. Prostate Cancer Prostatic Dis 9 (2006) 215
9. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176 (2006) 2414
10. Shariat S.F., Marberger M.J., Lotan Y., et al. Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. J Urol 176 (2006) 919
11. Karakiewicz P.I., Shariat S.F., Palapattu G.S., et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol 50 (2006) 1254
12. Stein J.P., Quek M.L., and Skinner D.G. Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 97 (2006) 232
13. Stein J.P., Quek M.L., and Skinner D.G. Lymphadenectomy for invasive bladder cancer. I. Historical perspective and contemporary rationale. BJU Int 97 (2006) 227
14. Roscigno M., Cozzarini C., Bertini R., et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 53 (2008) 794
15. Sanderson K.M., Stein J.P., and Skinner D.G. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer. Urol Oncol 22 (2004) 205
16. Kelsey J.L., Whittemore A.S., Evans A.S., et al. Methods in Observational Epidemiology. 2nd ed. (1996), Oxford University Press, Oxford, NY 232-242
17. Solsona E., Iborra I., Ricos J.V., et al. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term follow up of a prospective study. J Urol 159 (1998) 95
18. Dandekar N.P., Tongaonkar H.B., Dalal A.V., et al. Partial cystectomy for invasive bladder cancer. J Surg Oncol 60 (1995) 24
19. Herr H.W. Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 138 (1987) 1162
20. Bostrom P.J., Soloway M.S., Manoharan M., et al. Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy. J Urol 179 (2008) 91
21. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 12 (2006) 6663
22. Sternberg C.N., and Collette L. What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?. BJU Int 98 (2006) 487
23. Sternberg C.N., and Parmar M.K. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer. J Clin Oncol 19 (2001) 21S